Growth in infectious disease diagnostics market is primarily driven by increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, & growth in funding for research on infectious disease diagnostics.
The global infectious disease diagnostics market is expected to reach USD 19.35 billion by 2022 from USD 14.73 billion in 2017, at a CAGR of 5.6%. The report analyzes the market byproduct& service, disease type, technology, end user, and region.
Get Free Sample Papers of Infectious Disease Diagnostics Market with 170 Pages and 12 Company Profiles Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=258351 .
Infectious-disease diagnostics is procedure by which the causative agent of an infectious disease is identified & often characterized. In current diagnostics market, molecular diagnostics for infectious disease testing offers one of brightest areas for growth & innovation. Sometimes several different tests are done, typically in a specific order, based on results of previous test. Each test further narrows the possibilities.
“Key players in infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), biomérieux (France), Bio-Rad (US), and Roche (Switzerland).”
Infectious disease diagnostics market is segmented into assays, kits, & reagents; instruments; and services & software. The assays, kits, and reagents segment accounted for the largest share of the global infectious disease diagnostics market in 2017. The large share of this segment can be attributed to the increasing number of infectious disease diagnostic tests carried out.
Click Here for More Information on Infectious Disease Diagnostics Market with Forecast and Company Profiles at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=258351 .
The infectious disease diagnostics market in this report is segmented by product& service, disease type, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches& approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and profiles key players and core competencies in the infectious disease diagnostics market.
- Orthodontic product manufacturers, vendors, and distributors
- Venture capitalists and other government funding organizations
- Healthcare service providers (including hospitals and dental & orthodontic clinics)
- Research laboratories
- Academic institutes
- Market research and consultancy firms
- Government and independent regulatory authorities
Get Discount on “Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) – Global Forecast to 2022” report at http://www.rnrmarketresearch.com/contacts/discount?rname=258351 .
Geographically, the Infectious disease diagnostics market Asia Pacific is expected to register the highest CAGR during the forecast period. The growth of this regional segment can be attributed to the growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).
About Us –
RnRMarketResearch is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
Contact Number: + 1 888 391 5441
Email Id – [email protected]